Financials

  • Market Capitalization 36.4 M
  • Employee 19
  • Founded 2015
  • CEO N/A
  • Website www.abvcpharma.com
  • Headquarter Nevada, United States
  • FIGI BBG000Q844Z2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.46
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4429
ACTU
Actuate Therapeutics, Inc. - Common stock
1.57 USD+4.67%+12.14%-26.64%-61.52%37.56 M USD
4430
NNVC
NanoViricides, Inc. Common Stock
1.62 USD-1.82%+3.85%+24.62%+60.38%35.07 M USD
4446
RADX
Radiopharm Theranostics Limited American Depositary Shares
4.33 USD0.00%+0.70%+2.85%+1.88%34.13 M USD
4452
LSTA
Lisata Therapeutics, Inc. - Common Stock
3.66 USD-1.08%+10.57%+3.98%+41.31%33.33 M USD

Notizie